Assessing meaningful change in the Asthma Impairment and Risk Questionnaire

The Asthma Impairment and Risk Questionnaire (AIRQ) is a 10-item, yes/no, equally weighted control tool. Lower scores indicate better control. Moreover, 7 impairment items reflect previous 2-week symptoms, and 3 risk items assess previous 12-month exacerbations. The Follow-up AIRQ for use between an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of allergy, asthma, & immunology asthma, & immunology, 2024-08, Vol.133 (2), p.152-158
Hauptverfasser: McCann, William, Murphy, Kevin R., Zeiger, Robert S., Beuther, David A., Wise, Robert A., Reibman, Joan, George, Maureen, Gilbert, Ileen, Eudicone, James M., Gandhi, Hitesh N., Cutts, Katelyn, Coyne, Karin S., Chipps, Bradley
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 158
container_issue 2
container_start_page 152
container_title Annals of allergy, asthma, & immunology
container_volume 133
creator McCann, William
Murphy, Kevin R.
Zeiger, Robert S.
Beuther, David A.
Wise, Robert A.
Reibman, Joan
George, Maureen
Gilbert, Ileen
Eudicone, James M.
Gandhi, Hitesh N.
Cutts, Katelyn
Coyne, Karin S.
Chipps, Bradley
description The Asthma Impairment and Risk Questionnaire (AIRQ) is a 10-item, yes/no, equally weighted control tool. Lower scores indicate better control. Moreover, 7 impairment items reflect previous 2-week symptoms, and 3 risk items assess previous 12-month exacerbations. The Follow-up AIRQ for use between annual assessments has a 3-month recall period for exacerbation items. To evaluate the responsiveness of the AIRQ over time and identify a minimal important difference (MID). The AIRQ longitudinal study data were analyzed from patients with asthma aged 12 years and older. Anchor-based methods assessed differences in AIRQ scores relative to Patient Global Impression of Change, the accepted MIDs for St. George's Respiratory Questionnaire and Asthma Control Test, and exacerbation occurrence over 12 months. Baseline and 12-month data reflected 12-month recall AIRQ scores; Follow-up AIRQ scores were used for 3-, 6-, and 9-month analyses. A total of 1070 patients were included. The Patient Global Impression of Change rating of “much improved” was associated with AIRQ mean score changes from baseline to months 3, 6, 9, and 12 of −2.0, −1.9, −1.9, and −1.8, respectively. The mean AIRQ score change among patients who met the St. George's Respiratory Questionnaire MID (≥4-point decrease) was −1.8 at 6 and 12 months. The AIRQ mean scores decreased from baseline by −2.2 to −2.5 points at months 3, 6, 9, and 12 for patients who met the Asthma Control Test MID (≥ 3-point increase). A 2-point higher baseline AIRQ score was associated with a 1.7 odds ratio of 12-month exacerbation occurrence (95% CI, 1.53-1.89). A change score of 2 is recommended as the AIRQ MID.
doi_str_mv 10.1016/j.anai.2024.02.013
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2928586407</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1081120624000851</els_id><sourcerecordid>2928586407</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-9a027fb07a98e8cdb2ad073135eeec37e9b0e0decd536d3775fddd3c7d52eded3</originalsourceid><addsrcrecordid>eNp9kEtPwzAQhC0EoqXwBzggH7kkrO08JS5VxaOiEgLB2XLsTeuSOCVOkfj3uGrhyGn2MDOa_Qi5ZBAzYNnNOlZO2ZgDT2LgMTBxRMYsFUmUJCI7DjcULGIcshE5834NAKzIxCkZiUJkJU-zMXmaeo_eW7ekLSoXtN42VK-UWyK1jg4rpFM_rFpF5-1G2b5FN1DlDH21_oO-bNEPtnNhR4_n5KRWjceLg07I-_3d2-wxWjw_zGfTRaQTgCEqFfC8riBXZYGFNhVXBnLBRIqIWuRYVoBgUJtUZEbkeVobY4TOTcrRoBETcr3v3fTd526AbK3X2DTKYbf1kpe8SIssCaUTwvdW3Xfe91jLTW9b1X9LBnIHUa7lDqLcQZTAZYAYQleH_m3VovmL_FILhtu9AcOXXxZ76bVFp9EECnqQprP_9f8AgD2EDA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2928586407</pqid></control><display><type>article</type><title>Assessing meaningful change in the Asthma Impairment and Risk Questionnaire</title><source>Elsevier ScienceDirect Journals</source><creator>McCann, William ; Murphy, Kevin R. ; Zeiger, Robert S. ; Beuther, David A. ; Wise, Robert A. ; Reibman, Joan ; George, Maureen ; Gilbert, Ileen ; Eudicone, James M. ; Gandhi, Hitesh N. ; Cutts, Katelyn ; Coyne, Karin S. ; Chipps, Bradley</creator><creatorcontrib>McCann, William ; Murphy, Kevin R. ; Zeiger, Robert S. ; Beuther, David A. ; Wise, Robert A. ; Reibman, Joan ; George, Maureen ; Gilbert, Ileen ; Eudicone, James M. ; Gandhi, Hitesh N. ; Cutts, Katelyn ; Coyne, Karin S. ; Chipps, Bradley</creatorcontrib><description>The Asthma Impairment and Risk Questionnaire (AIRQ) is a 10-item, yes/no, equally weighted control tool. Lower scores indicate better control. Moreover, 7 impairment items reflect previous 2-week symptoms, and 3 risk items assess previous 12-month exacerbations. The Follow-up AIRQ for use between annual assessments has a 3-month recall period for exacerbation items. To evaluate the responsiveness of the AIRQ over time and identify a minimal important difference (MID). The AIRQ longitudinal study data were analyzed from patients with asthma aged 12 years and older. Anchor-based methods assessed differences in AIRQ scores relative to Patient Global Impression of Change, the accepted MIDs for St. George's Respiratory Questionnaire and Asthma Control Test, and exacerbation occurrence over 12 months. Baseline and 12-month data reflected 12-month recall AIRQ scores; Follow-up AIRQ scores were used for 3-, 6-, and 9-month analyses. A total of 1070 patients were included. The Patient Global Impression of Change rating of “much improved” was associated with AIRQ mean score changes from baseline to months 3, 6, 9, and 12 of −2.0, −1.9, −1.9, and −1.8, respectively. The mean AIRQ score change among patients who met the St. George's Respiratory Questionnaire MID (≥4-point decrease) was −1.8 at 6 and 12 months. The AIRQ mean scores decreased from baseline by −2.2 to −2.5 points at months 3, 6, 9, and 12 for patients who met the Asthma Control Test MID (≥ 3-point increase). A 2-point higher baseline AIRQ score was associated with a 1.7 odds ratio of 12-month exacerbation occurrence (95% CI, 1.53-1.89). A change score of 2 is recommended as the AIRQ MID.</description><identifier>ISSN: 1081-1206</identifier><identifier>ISSN: 1534-4436</identifier><identifier>EISSN: 1534-4436</identifier><identifier>DOI: 10.1016/j.anai.2024.02.013</identifier><identifier>PMID: 38369256</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><ispartof>Annals of allergy, asthma, &amp; immunology, 2024-08, Vol.133 (2), p.152-158</ispartof><rights>2024 The Authors</rights><rights>Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-9a027fb07a98e8cdb2ad073135eeec37e9b0e0decd536d3775fddd3c7d52eded3</citedby><cites>FETCH-LOGICAL-c400t-9a027fb07a98e8cdb2ad073135eeec37e9b0e0decd536d3775fddd3c7d52eded3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1081120624000851$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38369256$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McCann, William</creatorcontrib><creatorcontrib>Murphy, Kevin R.</creatorcontrib><creatorcontrib>Zeiger, Robert S.</creatorcontrib><creatorcontrib>Beuther, David A.</creatorcontrib><creatorcontrib>Wise, Robert A.</creatorcontrib><creatorcontrib>Reibman, Joan</creatorcontrib><creatorcontrib>George, Maureen</creatorcontrib><creatorcontrib>Gilbert, Ileen</creatorcontrib><creatorcontrib>Eudicone, James M.</creatorcontrib><creatorcontrib>Gandhi, Hitesh N.</creatorcontrib><creatorcontrib>Cutts, Katelyn</creatorcontrib><creatorcontrib>Coyne, Karin S.</creatorcontrib><creatorcontrib>Chipps, Bradley</creatorcontrib><title>Assessing meaningful change in the Asthma Impairment and Risk Questionnaire</title><title>Annals of allergy, asthma, &amp; immunology</title><addtitle>Ann Allergy Asthma Immunol</addtitle><description>The Asthma Impairment and Risk Questionnaire (AIRQ) is a 10-item, yes/no, equally weighted control tool. Lower scores indicate better control. Moreover, 7 impairment items reflect previous 2-week symptoms, and 3 risk items assess previous 12-month exacerbations. The Follow-up AIRQ for use between annual assessments has a 3-month recall period for exacerbation items. To evaluate the responsiveness of the AIRQ over time and identify a minimal important difference (MID). The AIRQ longitudinal study data were analyzed from patients with asthma aged 12 years and older. Anchor-based methods assessed differences in AIRQ scores relative to Patient Global Impression of Change, the accepted MIDs for St. George's Respiratory Questionnaire and Asthma Control Test, and exacerbation occurrence over 12 months. Baseline and 12-month data reflected 12-month recall AIRQ scores; Follow-up AIRQ scores were used for 3-, 6-, and 9-month analyses. A total of 1070 patients were included. The Patient Global Impression of Change rating of “much improved” was associated with AIRQ mean score changes from baseline to months 3, 6, 9, and 12 of −2.0, −1.9, −1.9, and −1.8, respectively. The mean AIRQ score change among patients who met the St. George's Respiratory Questionnaire MID (≥4-point decrease) was −1.8 at 6 and 12 months. The AIRQ mean scores decreased from baseline by −2.2 to −2.5 points at months 3, 6, 9, and 12 for patients who met the Asthma Control Test MID (≥ 3-point increase). A 2-point higher baseline AIRQ score was associated with a 1.7 odds ratio of 12-month exacerbation occurrence (95% CI, 1.53-1.89). A change score of 2 is recommended as the AIRQ MID.</description><issn>1081-1206</issn><issn>1534-4436</issn><issn>1534-4436</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kEtPwzAQhC0EoqXwBzggH7kkrO08JS5VxaOiEgLB2XLsTeuSOCVOkfj3uGrhyGn2MDOa_Qi5ZBAzYNnNOlZO2ZgDT2LgMTBxRMYsFUmUJCI7DjcULGIcshE5834NAKzIxCkZiUJkJU-zMXmaeo_eW7ekLSoXtN42VK-UWyK1jg4rpFM_rFpF5-1G2b5FN1DlDH21_oO-bNEPtnNhR4_n5KRWjceLg07I-_3d2-wxWjw_zGfTRaQTgCEqFfC8riBXZYGFNhVXBnLBRIqIWuRYVoBgUJtUZEbkeVobY4TOTcrRoBETcr3v3fTd526AbK3X2DTKYbf1kpe8SIssCaUTwvdW3Xfe91jLTW9b1X9LBnIHUa7lDqLcQZTAZYAYQleH_m3VovmL_FILhtu9AcOXXxZ76bVFp9EECnqQprP_9f8AgD2EDA</recordid><startdate>20240801</startdate><enddate>20240801</enddate><creator>McCann, William</creator><creator>Murphy, Kevin R.</creator><creator>Zeiger, Robert S.</creator><creator>Beuther, David A.</creator><creator>Wise, Robert A.</creator><creator>Reibman, Joan</creator><creator>George, Maureen</creator><creator>Gilbert, Ileen</creator><creator>Eudicone, James M.</creator><creator>Gandhi, Hitesh N.</creator><creator>Cutts, Katelyn</creator><creator>Coyne, Karin S.</creator><creator>Chipps, Bradley</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240801</creationdate><title>Assessing meaningful change in the Asthma Impairment and Risk Questionnaire</title><author>McCann, William ; Murphy, Kevin R. ; Zeiger, Robert S. ; Beuther, David A. ; Wise, Robert A. ; Reibman, Joan ; George, Maureen ; Gilbert, Ileen ; Eudicone, James M. ; Gandhi, Hitesh N. ; Cutts, Katelyn ; Coyne, Karin S. ; Chipps, Bradley</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-9a027fb07a98e8cdb2ad073135eeec37e9b0e0decd536d3775fddd3c7d52eded3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McCann, William</creatorcontrib><creatorcontrib>Murphy, Kevin R.</creatorcontrib><creatorcontrib>Zeiger, Robert S.</creatorcontrib><creatorcontrib>Beuther, David A.</creatorcontrib><creatorcontrib>Wise, Robert A.</creatorcontrib><creatorcontrib>Reibman, Joan</creatorcontrib><creatorcontrib>George, Maureen</creatorcontrib><creatorcontrib>Gilbert, Ileen</creatorcontrib><creatorcontrib>Eudicone, James M.</creatorcontrib><creatorcontrib>Gandhi, Hitesh N.</creatorcontrib><creatorcontrib>Cutts, Katelyn</creatorcontrib><creatorcontrib>Coyne, Karin S.</creatorcontrib><creatorcontrib>Chipps, Bradley</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of allergy, asthma, &amp; immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McCann, William</au><au>Murphy, Kevin R.</au><au>Zeiger, Robert S.</au><au>Beuther, David A.</au><au>Wise, Robert A.</au><au>Reibman, Joan</au><au>George, Maureen</au><au>Gilbert, Ileen</au><au>Eudicone, James M.</au><au>Gandhi, Hitesh N.</au><au>Cutts, Katelyn</au><au>Coyne, Karin S.</au><au>Chipps, Bradley</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessing meaningful change in the Asthma Impairment and Risk Questionnaire</atitle><jtitle>Annals of allergy, asthma, &amp; immunology</jtitle><addtitle>Ann Allergy Asthma Immunol</addtitle><date>2024-08-01</date><risdate>2024</risdate><volume>133</volume><issue>2</issue><spage>152</spage><epage>158</epage><pages>152-158</pages><issn>1081-1206</issn><issn>1534-4436</issn><eissn>1534-4436</eissn><abstract>The Asthma Impairment and Risk Questionnaire (AIRQ) is a 10-item, yes/no, equally weighted control tool. Lower scores indicate better control. Moreover, 7 impairment items reflect previous 2-week symptoms, and 3 risk items assess previous 12-month exacerbations. The Follow-up AIRQ for use between annual assessments has a 3-month recall period for exacerbation items. To evaluate the responsiveness of the AIRQ over time and identify a minimal important difference (MID). The AIRQ longitudinal study data were analyzed from patients with asthma aged 12 years and older. Anchor-based methods assessed differences in AIRQ scores relative to Patient Global Impression of Change, the accepted MIDs for St. George's Respiratory Questionnaire and Asthma Control Test, and exacerbation occurrence over 12 months. Baseline and 12-month data reflected 12-month recall AIRQ scores; Follow-up AIRQ scores were used for 3-, 6-, and 9-month analyses. A total of 1070 patients were included. The Patient Global Impression of Change rating of “much improved” was associated with AIRQ mean score changes from baseline to months 3, 6, 9, and 12 of −2.0, −1.9, −1.9, and −1.8, respectively. The mean AIRQ score change among patients who met the St. George's Respiratory Questionnaire MID (≥4-point decrease) was −1.8 at 6 and 12 months. The AIRQ mean scores decreased from baseline by −2.2 to −2.5 points at months 3, 6, 9, and 12 for patients who met the Asthma Control Test MID (≥ 3-point increase). A 2-point higher baseline AIRQ score was associated with a 1.7 odds ratio of 12-month exacerbation occurrence (95% CI, 1.53-1.89). A change score of 2 is recommended as the AIRQ MID.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38369256</pmid><doi>10.1016/j.anai.2024.02.013</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1081-1206
ispartof Annals of allergy, asthma, & immunology, 2024-08, Vol.133 (2), p.152-158
issn 1081-1206
1534-4436
1534-4436
language eng
recordid cdi_proquest_miscellaneous_2928586407
source Elsevier ScienceDirect Journals
title Assessing meaningful change in the Asthma Impairment and Risk Questionnaire
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T09%3A13%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessing%20meaningful%20change%20in%20the%20Asthma%20Impairment%20and%20Risk%20Questionnaire&rft.jtitle=Annals%20of%20allergy,%20asthma,%20&%20immunology&rft.au=McCann,%20William&rft.date=2024-08-01&rft.volume=133&rft.issue=2&rft.spage=152&rft.epage=158&rft.pages=152-158&rft.issn=1081-1206&rft.eissn=1534-4436&rft_id=info:doi/10.1016/j.anai.2024.02.013&rft_dat=%3Cproquest_cross%3E2928586407%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2928586407&rft_id=info:pmid/38369256&rft_els_id=S1081120624000851&rfr_iscdi=true